Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Food Chem Toxicol ; 118: 168-180, 2018 Aug.
Article in English | MEDLINE | ID: mdl-29738801

ABSTRACT

Obesity is a chronic and complex medical condition characterized by excessive fat accumulation and its complications include metabolic syndrome, diabetes and chronic inflammation. The aim of this study was to expand the knowledge about p-chloro-diphenyl diselenide (p-ClPhSe)2 effects on enzymes and proteins involved in the metabolism of lipids and carbohydrates in a model of neuroendocrine obesity induced by MSG. Male Wistar rats were treated during the first ten postnatal days with MSG (4 g/kg, s.c.) and received (p-ClPhSe)2 (10 mg/kg, i.g.) from 90th to 97th postnatal day. The hypothalamic function, insulin resistance and other biochemical parameters were determined in the rat blood, liver and skeletal muscle. The MSG administration induced hypothalamic neurotoxicity accompanied by metabolic disorders, including obesity, a transient insulin resistance, and metabolic alterations, demonstrated in the blood, liver and skeletal muscle, and lipotoxicity, characterized in the liver and skeletal muscle. The metabolic disorders in the liver and skeletal muscle were accompanied by the decrease in AMPK phosphorylation and activation of Akt. (p-ClPhSe)2 restored most of metabolic parameters altered by MSG administration in rats. The hypothalamic neurotoxicity induced by MSG was accompanied by metabolic disorders in rats, which were regulated by (p-ClPhSe)2.


Subject(s)
Metabolic Diseases/drug therapy , Metabolic Diseases/metabolism , Obesity/drug therapy , Obesity/metabolism , Organoselenium Compounds/therapeutic use , Sodium Glutamate/administration & dosage , Alanine Transaminase/blood , Animals , Animals, Newborn , Aspartate Aminotransferases/blood , Cholesterol/blood , Creatinine/blood , Disease Models, Animal , Feeding Behavior/drug effects , Glucose Tolerance Test , Glucose-6-Phosphatase/metabolism , Glycated Hemoglobin/metabolism , Homeostasis , Hypothalamus/drug effects , Liver/drug effects , Liver/enzymology , Liver Glycogen/metabolism , Male , Metabolic Diseases/chemically induced , Muscle, Skeletal/metabolism , Obesity/chemically induced , Organoselenium Compounds/pharmacology , Rats, Wistar , Triglycerides/blood , Triglycerides/metabolism
2.
Physiol Behav ; 151: 298-307, 2015 Nov 01.
Article in English | MEDLINE | ID: mdl-26253212

ABSTRACT

Preliminary findings suggest that food intake reduction induced by p-chloro-diphenyl diselenide [(p-ClPhSe)2] in rats is mediated by a satiating action; however, additional experiments are necessary to clarify its actions. The purpose of this study was to investigate the effects of diets supplemented with (p-ClPhSe)2 on feeding behavior of rats as well as the (p-ClPhSe)2 effectiveness in producing aversive reactions or specific flavor. The results demonstrated that behavioral satiety sequence (BSS) was preserved in animals exposed to (p-ClPhSe)2-supplemented diets (0.01 and 0.1%) and associated with a shift of the onset of resting to the left indicating a satiating action at the first contact. In addition, the frequency, the mean duration and the mean size of meals were decreased in rats exposed to a 0.1% (p-ClPhSe)2 diet. Alternatively, a second contact with a 0.01% (p-ClPhSe)2 diet caused disruption of BSS and pronounced changes in the meal pattern, suggesting that it produces aversiveness. In fact, rats developed a significant taste aversion to the saccharin solution after receiving the administration of (p-ClPhSe)2 (1 and 10mg/kg; i.p.). Lastly, a diet containing 0.1% of (p-ClPhSe)2 seems to alter the palatability of food given that rats had a preference for the control diet. The findings of the present study suggest that (p-ClPhSe)2 reduced the food intake of rats by inducing a satiating action at the first contact, but it also produced aversive reactions when rats were re-exposed to it. A specific flavor seems also to contribute to (p-ClPhSe)2 suppressant effects on feeding.


Subject(s)
Diet , Dietary Supplements , Feeding Behavior , Organoselenium Compounds/administration & dosage , Adipose Tissue , Animals , Avoidance Learning , Body Weight , Choice Behavior , Conditioning, Psychological , Feeding Behavior/physiology , Male , Motor Activity , Rats, Wistar , Satiation/physiology , Taste Perception , Time Factors
3.
Psychopharmacology (Berl) ; 232(13): 2239-49, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25563236

ABSTRACT

RATIONALE: The searching for safe and effective antiobesity drugs has been the subject of intense research. Previous studies have shown several pharmacological applications of organoselenium compounds; however, their possible anorectic-like actions have not been investigated. OBJECTIVE: This study aims to investigate the effects of (PhSe)2 and (p-ClPhSe)2 on feeding behavior of rats and their potential as weight-reducing agents. METHODS: The effects of intraperitoneal administration of diselenides were investigated through the microstructural pattern of feeding behavior, behavioral satiety sequence (BSS), hypothalamic serotonin (5-HT) uptake, body weight, and epididymal fat content of male rats. RESULTS: Our findings demonstrated that food intake of fasted rats was reduced by both diselenides (1 and 10 mg/kg). Diphenyl diselenide [(PhSe)2] (1 mg/kg) and p-chloro-diphenyl diselenide [(p-ClPhSe)2] (10 mg/kg) decreased the frequency, mean duration, and mean size of meals compared with the control treatment. The BSS structure was preserved when organoselenium compounds (1 mg/kg) were administered, and it was associated to a displacement to the left when the resting period started indicating a satiating action. Inhibition of 5-HT uptake in the hypothalamus (∼20 %) was also found in rats treated with low doses of (PhSe)2 and (p-ClPhSe)2 (1 mg/kg). Treatments with a high dose of both diselenides (10 mg/kg) carried out for 7 days induced weight loss and epididymal fat reduction in sated rats. CONCLUSION: This study suggests that diselenides caused a satiating action in rats that could be partially explained by the inhibition of hypothalamic 5-HT uptake. These organoselenium compounds were potential weight-reducing agents when repeatedly administered.


Subject(s)
Benzene Derivatives/pharmacology , Feeding Behavior/drug effects , Organoselenium Compounds/pharmacology , Satiety Response/drug effects , Animals , Body Weight/drug effects , Body Weight/physiology , Dose-Response Relationship, Drug , Feeding Behavior/physiology , Male , Rats , Rats, Wistar , Satiety Response/physiology
4.
Microbiol Res ; 168(9): 563-8, 2013 Nov 07.
Article in English | MEDLINE | ID: mdl-23683588

ABSTRACT

The aim of this study was to explore if 2,2'-dithienyl diselenide (DTDS) pro-oxidant activity is related to its antibacterial and antifungal actions. The antimicrobial activity of DTDS against bacterial and fungal was investigated in the broth microdilution assay (3.02-387 µg/ml). Additionally, the survival curve of microorganisms in the presence of DTDS (12.09-193.5 µg/ml) was performed. The involvement of pro-oxidant activity in the DTDS antimicrobial action was investigated by supplementing the growth medium with 10 mM glutathione or ascorbic acid in the disk diffusion technique (0.64-640 µgDTDS/discs). The levels of reactive species (RS) induced by 25 mM DTDS were also determined. The results demonstrated that DTDS was effective in preventing the Gram-positive bacteria and Candida albicans growth. The minimum inhibitory concentration, twice and half concentrations of DTDS confirmed that the activity of compound was bactericidal for some microorganisms (Enterococcus faecalis, and Staphylococcus saprophyticus), bacteriostatic for Bacillus cereus and fungistatic for C. albicans. Antibacterial and antifungal actions of DTDS are related to the increase of reactive species levels. The presence of antioxidants in the growth medium avoided the DTDS antimicrobial action. In conclusion, DTDS showed promising antibacterial and antifungal actions, possibly related to its pro-oxidant activity.


Subject(s)
Anti-Infective Agents/pharmacology , Candida albicans/drug effects , Gram-Positive Bacteria/drug effects , Organoselenium Compounds/pharmacology , Reactive Oxygen Species/pharmacology , Thiophenes/pharmacology , Culture Media/chemistry , Microbial Sensitivity Tests , Microbial Viability/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL